Pfizer sets ambitious 2025 guidance with revenue of up to $64 billionDecember 17, 2024 Pfizer forecasts 2025 revenue of up to $64 billion and adjusted earnings growth, navigating cost challenges amid Medicare changes and advancing promising drug pipeline assets, including its weight-loss candidate.
New study highlights potential of Pfizer’s oral weight loss drug as alternative to OzempicMay 22, 2023 A peer-reviewed study released on Monday reveals that an oral weight loss drug developed by Pfizer demonstrates similar efficacy and…
